000			01894nas a22002895i 4500
001			1179-1942
003			DE-He213
005			20260610082442.0
007			cr nn 008mamaa
008			150723s||||||||sz uu poo|||||| b|EN |d
022			_a1179-1942
024	7		_a10.1007/40264.1179-1942 _2doi
210	1	0	_aDrug Saf
245	1	0	_aDrug Safety _h[electronic resource] : _bThe Official Journal of the International Society of Pharmacovigilance [ISoP] / _cedited by Nitin Joshi.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Adis.
300			_bonline resource.
520			_aDrug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics. Editorials and commentaries on topical issues.
650		0	_aPharmacovigilance.
650		0	_aPharmacology.
650	1	4	_aDrug Safety and Pharmacovigilance.
650	2	4	_aPharmacology.
700	1		_aJoshi, Nitin. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x0114-5916
856	4	0	_uhttps://doi.org/10.1007/40264.1179-1942 _zHybrid
999			_c973 _d973